Completed PHASE3 INTERVENTIONAL NCT00046176

A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients

A Phase III, 48-Week, Open-Label, Randomized, Multicenter Study of the Safety and Efficacy of the Abacavir/Lamivudine Fixed-Dose Combination Tablet Administered QD Versus Abacavir + Lamivudine Administered BID in Combination With a PI or NNRTI in Antiretroviral Experienced Patients.

Sponsor: ViiV Healthcare

Conditions HIV Infection Infection, Human Immunodeficiency Virus I

Interventions abacavir abacavir/lamivudine lamivudine

Updated 7 times since 2017 Last updated: Mar 20, 2020 Started: Aug 26, 2002 Primary completion: May 17, 2004 Completion: May 17, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates HIV Infection and Infection, Human Immunodeficiency Virus I and is currently completed. ViiV Healthcare leads this study, which shows 7 recorded versions since 2002 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Apr 2020 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Jun 2018 — Apr 2020 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Aug 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

ViiV Healthcare

Data source: ViiV Healthcare

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Akron, United States , Atlanta, United States , Augusta, United States , Baltimore, United States , Charlotte, United States , Columbia, United States , Dallas, United States , Decatur, United States , Denver, United States , Durham, United States and 31 more locations